Production and Investigation of Controlled Drug Release Properties of Tamoxifen Loaded Alginate-Gum Arabic Microbeads

Abstract

The entrapment of tamoxifen onto alginate-gum arabic beads and the production of controlled drug release was investigated in this study. The polymeric system that would provide the controlled release of tamoxifen was formed using alginate and gum arabic. In the first phase of the study, the optimization of the alginate-gum arabic beads production was conducted; then the study continued with drug entrapment experiments. Tamoxifen entrapment yield was found to be approximately 90% of initial tamoxifen concentration. In vitro drug release experiments were performed in simulated gastric juice and intestinal fluid where the tamoxifen release was 20% and 53% of the initial drug present, respectively. As a result of this study, it is expected that a valuable contribution to the field of controlled drug release system production is realized.

References

1. Kumar R, Majeti NV. Nano and microparticles as controlled drug delivery devices. Journal of Pharmaceutical Sciences. 2000; 3(2):234-258. http://www.ncbi.nlm.nih.gov/pubmed/10994037.
2. Jana S, Ghandi A, Sen KK, Basu SK. Natural Polymers and their application in drug delivery and biomedical field. 2011; 1(1):16-27. http://www.pharmascitech.in/admin/php/uploads/6_pdf.pdf.
3. Kalia S., Averous L. Biopolymers: Biomedical and Environmental Applications. Scriven Publishing LLC., Massachusetts. 2011. ISBN: 978-0-470-63923-8.
4. Guarino V, Caputo T, Altobelli R, Ambrosio L. Degradation properties and metabolic activity of alginate and chitosan polyelectrolytes for drug delivery and tissue engineering applications. AIMS Materials Science. 2015; 2(4): 497-502. DOI: 10.3934/matersci.2015.4.497.
5. http://www.justpaint.org/the-science-behind-qor/
6. Ogura K, Ishikawa Y, Kaku T, Nishiyama T, Ohnuma T, Muro K, Hiratsuka A. Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4. Biochemical Pharmacology. 2006; 71(9): 1358-1369. DOI: 10.1016/j.bcp.2006.01.004.
7. Jensen, SC, Peppers, MP. Pharmacology and drug administration for imaging technologists. Elsevier Health Sciences, 2013. ISBN: 978-0-323-03075-5.
8. MacGregor JI, Jordan VC. Basic guide to the mechanisms of antiestrogen action. Pharmacological Reviews. 1998; 50(2): 151–196. PMID: 9647865.

9. Brigger I, Chaminade P, Marsaud V, Appel M, Besnard M, Gurny R, Couvreur P. Tamoxifen encapsulation within polyethyleneglycol-coated nanospheres. A new antiestrogen formulation. International Journal of Pharmaceutics. 2001; 214(1): 37-42. DOI:10.1016/S0378-5173(00)00628-1.
10. Cavallaro G, Maniscalco L, Licciardi M, Giammona G. Tamoxifen‐loaded polymeric micelles: preparation, physico‐chemical characterization and in vitro evaluation studies. Macromolecular Bioscience. 2004; 4(11): 1028-1038. DOI: 10.1002/mabi.200400089.
11. Chawla JS, Amiji MM. Biodegradable poly (ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. International Journal of Pharmaceutics. 2002; 249(1):127-138. DOI:10.1016/S0378-5173(02)00483-0.
12. Maji R, Dey NS, Satapathy B., Mukherjee B, Mondal S. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy. International Journal of Nanomedicine. 2014; 9, 3107. DOI:10.2147/IJN.S63535.
13. Coppi G, Iannuccelli V. Alginate/chitosan microparticles for tamoxifen delivery to the lymphatic system. International Journal of Pharmaceutics. 2009; 367(1): 127-132. DOI:10.1016/j.ijpharm. 2008.09.040.
14. Shaker DS, Shaker MA, Klingner A, Hanafy MS. In situ thermosensitive Tamoxifen citrate loaded hydrogels: an effective tool in breast cancer loco-regional therapy. Journal of Drug Delivery Science and Technology. 2016; 35:155-164. DOI:10.1016/j.jddst.2016.05.007.
15. Yarman A, Scheller FW. The first electrochemical MIP sensor for tamoxifen. Sensors. 2014; 14(5): 7647-7654. DOI: 10.3390/s140507647.
16. Malakar M,Nayak AK, Pal D, Jana P. Potato starch blended alginate beads for prolonged release of tolbutamide: Development by statistical optimization and in vitro characterization. Asian Journal of Pharmaceutics. 2013; 7: 43-51. DOI: 10.4103/0973-8398.110935.
17. Nayak AK, Das B, Maji R. Calcium alginate/gum arabic beads containing glibenclamide: Development and in vitro characterization. International Journal of Biological Macromolecules. 2012; 51(5): 1070-1078. DOI:10.1016/j.ijbiomac.2012.08.021.
18. Lee, B. J., Min, G. H., & Kim, T. W. Preparation and in vitro release of melatonin-loaded multivalent cationic alginate beads. Archives of Pharmacal Research. 1996; 19(4): 280-285. DOI:10.1007/BF02976241.